Dugel Pravin
Officer, Director at OCUL; EVP, Chief Strategy & Business at IVERIC bio, Inc.
- Sold, on record
- $3.2M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Aug 24, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- OCULOCULAR THERAPEUTIX, INCOfficer, Director
- IVERIC bio, Inc.EVP, Chief Strategy & Business
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- OCUL334,647 shares
- IVERIC bio, Inc.28,301 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale OCULRoutineFeb 24, 2025 2025
Sold 21,475 shares at $6.87 ($148k)
Dugel Pravin, Officer, Director
10b5-1 planSold 0.6% of holdings ($24.3M position)3.5M shares left1x usual sizeFiling
- 2 Form 4 sale OCULRoutineMay 23, 2025 +88 days
Sold 21,219 shares at $7.18 ($152k)
Dugel Pravin, Officer, Director
10b5-1 planSold 0.6% of holdings ($25.3M position)3.5M shares left1x usual sizeFiling
- 3 Form 4 sale OCULRoutineAug 25, 2025 +94 days
Sold 21,494 shares at $12.04 ($259k)
Dugel Pravin, Officer, Director
10b5-1 planSold 0.7% of holdings ($39.1M position)3.2M shares left1x usual sizeFiling
- 4 Form 4 sale OCULRoutineNov 24, 2025 +91 days
Sold 19,530 shares at $12.04 ($235k)
Dugel Pravin, Officer, Director
10b5-1 planSold 0.6% of holdings ($38.3M position)3.2M shares left0.9x usual sizeFiling
- 5 Form 4 sale OCULUnusualFeb 12, 2026 +80 days
Sold 124,882 shares at $9.04 ($1.1M)
Dugel Pravin, Officer, Director
10b5-1 planSold 4% of holdings ($28.5M position)3M shares left5.9x usual sizeFiling
- 6 Form 4 sale OCULRoutineFeb 23, 2026 +11 days
Sold 20,056 shares at $8.28 ($166k)
Dugel Pravin, Officer, Director
10b5-1 planSold 0.7% of holdings ($25.1M position)3M shares left0.9x usual sizeFiling
- 7 Form 4 sale OCULRoutineMay 26, 2026 +92 days
Sold 21,156 shares at $8.20 ($173k)
Dugel Pravin, Officer, Director
10b5-1 planSold 0.8% of holdings ($21.5M position)2.6M shares left1x usual sizeFiling
- 8 Form 4 sale OCULRoutineAug 24, 2026 +90 days
Sold 21,649 shares at $10.77 ($233k)
Dugel Pravin, Officer, Director
10b5-1 planSold 0.8% of holdings ($27.4M position)2.5M shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Aug 26, 2026 | OCUL | Officer, Director | Form 4 sale | 21,649 | $233k | 0.8% | Routine | SEC |
| May 26, 2026 | May 28, 2026 | OCUL | Officer, Director | Form 4 sale | 21,156 | $173k | 0.8% | Routine | SEC |
| Feb 23, 2026 | Feb 25, 2026 | OCUL | Officer, Director | Form 4 sale | 20,056 | $166k | 0.7% | Routine | SEC |
| Feb 12, 2026 | Feb 17, 2026 | OCUL | Officer, Director | Form 4 sale | 124,882 | $1.1M | 4.0% | Unusual | SEC |
| Nov 24, 2025 | Nov 26, 2025 | OCUL | Officer, Director | Form 4 sale | 19,530 | $235k | 0.6% | Routine | SEC |
| Aug 25, 2025 | Aug 27, 2025 | OCUL | Officer, Director | Form 4 sale | 21,494 | $259k | 0.7% | Routine | SEC |
| May 23, 2025 | May 27, 2025 | OCUL | Officer, Director | Form 4 sale | 21,219 | $152k | 0.6% | Routine | SEC |
| Feb 24, 2025 | Feb 26, 2025 | OCUL | Officer, Director | Form 4 sale | 21,475 | $148k | 0.6% | Routine | SEC |
| Nov 25, 2024 | Nov 27, 2024 | OCUL | Officer, Director | Form 4 sale | 20,680 | $186k | 2.5% | Routine | SEC |
| Nov 25, 2024 | Nov 25, 2024 | OCUL | Officer | Form 144 notice | 17,783 | $160k | Notice | SEC | |
| Nov 25, 2024 | Nov 25, 2024 | OCUL | Officer | Form 144 notice | 2,897 | $26k | Notice | SEC | |
| Aug 23, 2024 | Aug 27, 2024 | OCUL | Officer, Director | Form 4 sale | 20,880 | $188k | 2.5% | Routine | SEC |
| Aug 23, 2024 | Aug 23, 2024 | OCUL | Officer | Form 144 notice | 20,880 | $188k | Notice | SEC | |
| May 23, 2024 | May 28, 2024 | OCUL | Officer, Director | Form 4 sale | 21,626 | $125k | 2.5% | Routine | SEC |
| May 23, 2024 | May 23, 2024 | OCUL | Officer | Form 144 notice | 21,626 | $125k | Notice | SEC | |
| Apr 5, 2021 | Apr 5, 2021 | IVERIC bio, Inc. | EVP, Chief Strategy & Business | Form 4 sale | 28,301 | $179k | 40.4% | Unusual | SEC |